• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

The Worldwide Market for Point-of-Care (POC) Diagnostics, 7th Edition (Infectious Disease Testing, Cancer Point of Care, Rapid Coagulation, Urine Testing, Lipids, Pregnancy, Glucose and Other Tests)

$5,500.00 – $11,000.00

Clear
SKU: 20-026 Categories: Diagnostics Market Research, Point-of-Care Diagnostics Tags: POC Colon Cancer Screening Market, POC Glucose Testing Market, POC Infectious Disease Testing Market, POC Professional Testing Market, POC Self-Testing Market, POC Testing Market, Point-of-Care (POC) Diagnostics, Point-of-care (POC) Testing Pages: 599
  • Description
  • Table of Contents
  • Latest reports

Description

This report represents the 7th edition of a fast-growing and competitive category of the in vitro diagnostic market. Point-of-care (POC) tests are diagnostics performed outside the central laboratory or executed via decentralized testing. POC testing has skyrocketed in the last 20 years as demand for accurate and fast testing has grown both inside and outside the hospital setting. The increasing introduction of transportable, portable, and handheld instruments has resulted in the migration of POC testing from the hospital environment to a range of medical environments including the workplace, home, disaster care and, most recently, convenience clinics.

The 7th edition of Kalorama’s Worldwide Market for Point-of-Care (POC) Diagnostics takes a deep look at the POC diagnostic industry, part of a paradigm shift from curative medicine to predictive, personalized and preemptive medicine.

Global Market Analysis

The global POC testing market is composed of two major categories: professional testing, which includes physician office labs, clinic labs, employer labs and hospital labs, and self-testing, which includes home, drug store testing and continuous glucose testing. The report presents market analysis by product categories, market analysis by subcategory, market analysis by device technology, market analysis by country (including the United States, Europe, Japan, and rest of world), and competitive analysis. The following global market data is provided:

  • Global POC Test Market, 2019-2024 (in millions $ at manufacturer level)
  • Global POC Testing Market Analysis by Product Category, 2019 (in millions $) (Self-Testing, Professional Testing, Total)
  • Global POC Self-Testing Market Analysis by Product Category, 2019 (in millions$) (Glucose [includes CGM], Pregnancy & Fertility, Fecal Occult Blood, Rapid Coagulation, Drugs of Abuse, Urine, Infectious Disease, Lipid, Total)
  • Global POC Self-Testing Market Analysis by Product Category, 2019 (by %) (Infectious Disease, Urine, DOA, Coagulation, FOB, Pregnancy, Glucose)
  • Global POC Professional Testing Market Analysis by Product Subcategory, 2019 (in millions$) (Drugs of Abuse, Glucose includes HbA1c, Blood & Electrolytes, Infectious Disease, Rapid Coagulation, Fecal Occult Blood, Cardiac Markers, Lipid, Pregnancy & Fertility, Miscellaneous, Urine, Cancer Tumor Markers, Total)
  • Global POC Professional Testing Market Analysis by Product Subcategory, 2019 (by %) (Tumor Markers, Urine, Misc, Pregnancy, Lipid, Cardiac Markers, Rapid Coag, FOB, Infectious Disease, Blood/ Electrolytes, Glucose/ HbA1c, DOA)
  • POC Testing by End-user, 2019 (%) (Hospitals, Others)
  • Global POC Market by Technology by Sales, 2019 (%) (LFA, Biosensors, Analyzers, Strips)

Regional Market Analysis

The POC market is also broken out by geographic region:

  • Global POC Testing Analysis by Region/Country, 2019 (in millions $) (United States, Europe, Japan, ROW, Total)
  • Global POC Testing Market Analysis by European Region, 2019 (in millions $) (W. Europe, E. Europe, Total)
  • Europe POC Testing Percentage Participation, by Country, 2019 (Germany, UK, France, Italy, Switzerland/ Sweden, Spain, Other)
  • Global POC Testing Market Analysis by Rest of World Region/Country, 2019 (in millions $) (Latin America and Mexico, China, Australia, South Korea, India, Other, Total)
  • POC Blood Glucose Testing Regional Market Analysis, 2019 (US, Europe, Japan, RoW)
  • POC Blood and Electrolytes Testing Regional Market Analysis, 2019 (US, Europe, Japan, RoW)
  • POC Rapid Coagulation Testing Regional Market Analysis, 2019 (US, Europe, Japan, RoW)
  • POC Rapid Cardiac Markers Testing Regional Market Analysis, 2019 (US; Europe; Japan; Latin America, India, Asia Pacific and the Middle East; RoW)
  • POC Substance Abuse Testing Regional Market Analysis, 2019 (US, Europe, Japan, RoW)
  • POC Pregnancy and Fertility Testing Regional Market Analysis, 2019 (US, Europe, Japan, RoW)
  • POC Colon Cancer Screening/FOB Testing Regional Market Analysis, 2019 (US, Europe, Japan, RoW)
  • POC Infectious Disease Testing Regional Market Analysis, 2019 (US, Europe, Japan, RoW)
  • POC Lipid Testing Regional Market Analysis, 2019 (US, Europe, Japan, RoW)
  • POC Cancer Tumor Marker Testing Regional Market Analysis, 2019 (US, Europe, Japan, RoW)
  • POC Urine Testing Regional Market Analysis, 2019 (US, Europe, Japan, RoW)
  • POC Miscellaneous Testing Regional Market Analysis, 2019 (US, Europe, Japan, RoW)

Segment Size and Growth

POC test devices have contributed significantly to the growth of the overall diagnostics market over the past 10 years. More diagnostic manufacturers have pursued CLIA waiver status for their POC devices and CE Mark for POC or self-use. At the same time more, decentralized test venues invest in non-waived rapid tests and instruments. POC testing appears to be headed for an even bigger role in diagnosis and monitoring patient care. New technologies are allowing POC devices to produce quantitative lab-quality test results that can be transferred automatically to an information system, a remote caregiver service for consultation or an electronic medical record. As the menu for point-of-care testing continues to expand, the report looks in-depth at the following market segments:

  • Global POC Glucose (including CGM and HbA1c) Testing Market Analysis, 2019-2024 (in millions of dollars at the manufacturer’s level)
  • Global POC Diabetes Sales by Test Category, 2019-2024 (Glucose, Self-test; Glucose, professional; Glucose, continuous; HbA1c, POC; TOTAL; $ millions)
  • Global POC Glucose Self-Testing Market (excludes continuous glucose devices) 2019-2024 (in millions $ at manufacturer level)
  • Global POC Continuous Glucose Self-Testing Market 2019-2024 (in millions $ at manufacturer level)
  • Global POC Glucose Professional Testing Market (excludes HbA1c testing) 2019-2024 (in millions $ at manufacturer level)
  • Global POC Glucose HbA1c Professional Testing Market 2019-2024 (in millions $ at manufacturer level)
  • Global POC Blood and Electrolytes Testing Market Analysis, 2019-2024 (in millions of dollars at the manufacturer’s level)
  • Global POC Blood & Electrolytes Revenues by Test Category, 2019-2024 ($ millions) (Blood Gases & Electrolytes [inc critical care], Hematocrit/Hemoglobin, WBC other routine)
  • Global POC Blood & Electrolytes Sales by Test Category, 2019-2024 ($ millions) (Blood Gases & Electrolytes [inc critical care], Hematocrit/Hemoglobin, WBC other routine)
  • Global Rapid Coagulation Testing Market Analysis, 2019-2024 (in millions of dollars at the manufacturer’s level)
  • Total Rapid Cardiac Markers Tests Market Analysis, 2019-2024 (in millions of dollars at the manufacturer’s level)
  • Global POC Drugs of Abuse Testing Market Analysis, 2019-2024 (in millions of dollars at the manufacturer’s level)
  • Global POC Drugs of Abuse Self Testing Market, 2019-2024 (includes continuous glucose devices)
  • Global POC Drugs of Abuse Professional Testing Market Analysis, 2019-2024 (in millions of dollars at the manufacturer’s level)
  • Global POC Pregnancy and Fertility Testing Market Analysis, 2019-2024 (in millions of dollars at the manufacturer’s level)
  • POC Pregnancy and Fertility Self-Testing Market Analysis, 2019-2024 (in millions of dollars at the manufacturer’s level)
  • POC Pregnancy and Fertility Professional Testing Market Analysis, 2019-2024 (in millions of dollars at the manufacturer’s level)
  • Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market Analysis: 2019-2024 (in millions of dollars at the manufacturer’s level)
  • POC Colon Cancer Screening/Fecal Occult Blood Self-Testing Market Analysis, 2019-2024 (in millions of dollars at the manufacturer’s level)
  • POC Colon Cancer Screening/Fecal Occult Blood Professional Testing Market Analysis, 2019-2024 (in millions of dollars at the manufacturer’s level)
  • Global POC Infectious Disease Testing Market Analysis: 2019-2024 (in millions of dollars at the manufacturer’s level)
  • Global POC Infectious Disease Revenues and Percent of Infectious Disease Market by Disease Type, 2019 (in millions $) (Influenza, HIV, STD, Hepatitis, Malaria, C. difficile, E. coli, H. pylori, Home Test/OTC, Others, Total)
  • POC Infectious Disease Self-Testing Market Analysis, 2019-2024 (in millions of dollars at the manufacturer’s level)
  • POC Infectious Disease Professional Testing Market Analysis, 2019-2024 (in millions of dollars at the manufacturer’s level)
  • Global POC Infectious Disease Revenues and Percent of Infectious Disease Market by Disease Type, 2018 (in millions $) (Influenza, HIV, STD, Hepatitis, Malaria, C. difficile, E. coli, H. pylori, Home Test/OTC, Others, Total)
  • Global POC Lipid Testing Market Analysis, 2019-2024 (in millions of dollars at the manufacturer’s level)
  • POC Lipid Self-Testing Market Analysis, 2019-2024 (in millions of dollars at the manufacturer’s level)
  • POC Lipid Professional Testing Market Analysis, 2019-2024 (in millions of dollars at the manufacturer’s level)
  • Global POC Cancer Testing Market Analysis, 2019-2024 (in millions of dollars at the manufacturer’s level)
  • Global POC Urine Testing Market Analysis, 2016-2028 (in millions of dollars at the manufacturer’s level)
  • POC Urine Self-Testing Market Analysis, 2019-2024 (in millions of dollars at the manufacturer’s level)
  • POC Urine Professional Testing Market Analysis, 2019-2024 (in millions of dollars at the manufacturer’s level)
  • Global Miscellaneous POC Testing Market Analysis, 2019-2024 (in millions of dollars at the manufacturer’s level)
  • Global POC Miscellaneous Sales by Test Category, 2019-2024 (Microbiology, TSH, Allergy, Autoimmune, Others TOTAL; $ millions) (Microbiology, TSH, Allergy, Autoimmune, Others, Total)

Competitor Analysis

Developing and developed markets alike have room to grow due to an aging population worldwide, drawing companies both large and small into the development and/or marketing of POC tests. Among the innovative competitors discussed within the report’s corporate profiles are:

  • 1 Step Detect Associates, LLC
  • Abaxis, Inc.
  • Abbott Laboratories
  • Abingdon Health, Ltd.
  • AccessBio, Inc.
  • AccuBioTech Co, Ltd.
  • ACON Laboratories, Inc
  • Aerscher Diagnostics, LLC
  • Akers Biosciences, Inc.
  • Alfa Scientific Designs, Inc
  • American Bio Medica Corporation
  • AmniSure International
  • Aquila Diagnostic Systems, Inc
  • Arkray, Inc.
  • Arlington Scientific, Inc.
  • Artron Laboratories, Inc
  • Ascensia Diabetes Care Holdings AG
  • Ativa Medical Corporation
  • Atlas Link Biotech Co., Ltd
  • Audit Diagnostics
  • Augurix Diagnostic
  • Autobio Diagnostics Co., Ltd
  • Axxin
  • Beckman Coulter, Inc
  • Becton Dickinson (BD)
  • Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
  • Bhat Bio-Tech India Private Ltd. (BBI)
  • binx health
  • bioLytical Laboratories
  • BioMedomics, Inc
  • Biomeme, Inc
  • Biomerica, Inc.
  • bioMérieux SA
  • Biophor Diagnostics, Inc
  • Bio-Rad Laboratories Inc.
  • Bioscan Screening Systems, Inc.
  • Biosensia Ltd.
  • Biotron Diagnostics, Inc.
  • BNTX Inc.
  • Boditech Med Inc
  • Boson Biotech Co. Ltd
  • Calypte Biomedical Corporation
  • CARE Products, Inc.
  • Cepheid, Inc
  • Chembio Diagnostics, Inc.
  • Church & Dwight Co. Inc
  • Clarity Diagnostics, LLC
  • Confirm Biosciences
  • CTK Biotech, Inc.
  • Daktari Diagnostics
  • Danaher Corporation
  • Dexcom, Inc
  • DIALAB GmbH
  • DiaSys Diagnostic Systems GmbH
  • Diazyme Laboratories, Inc.
  • DNA Electronics Ltd. (DNAe)
  • Drägerwerk AG & Co. KGaA
  • Dr. Fooke-Achterrath Laboratorien GmbH
  • DRG International, Inc.
  • DxGen Corp.
  • Eiken Chemical Co Ltd.
  • EKF Diagnostics Holdings plc
  • ELITechGroup, Inc.
  • Enterix, Inc. (Clinical Genomics)
  • Entopsis
  • Eurobio Scientific
  • Eurolyser Diagnostica GmbH
  • Exact Sciences
  • Exalenz Bioscience Ltd.
  • EY Laboratories
  • Fio Corporation
  • First Check Diagnostics LLC
  • GenBio
  • genedrive plc
  • GenePOC
  • GeTein BioMedical, Inc.
  • GlysBy snc
  • Helena Laboratories
  • Hemosure, Inc.
  • HORIBA, Ltd.
  • Immunosciences Lab, Inc.
  • Immunostics, Inc
  • InSilixa, Inc
  • Instrumentation Laboratory
  • JAL Innovation PTE LTD
  • Jant Pharmacal Corporation
  • J. Mitra & Co Pvt. Ltd
  • LamdaGen Corporation
  • LifeScan, Inc
  • LifeSign, LLC
  • Loop Medical
  • Macherey-Nagel GmbH & Co. KG
  • Magnasense Technologies
  • MBio Diagnostics, Inc
  • Medix Biochemica
  • MedMira, Inc
  • Medtronic, Inc.
  • Menarini Diagnostics srl.
  • Meridian Bioscience, Inc
  • MiCo BioMed USA
  • Nano-Ditech Corporation
  • NG Biotech
  • Noble Medical, Inc
  • Nova Biomedical Corp.
  • NuGenerex Diagnostics
  • Oasis Diagnostics Corporation
  • Operon S.A.
  • OPKO Health, Inc
  • OPTI Medical Systems, Inc
  • OraSure Technologies, Inc.
  • Polymedco, Inc
  • Polymed Therapeutics Inc.
  • Polymer Technologies, Inc (PTS Diagnostics)
  • Preventis GmbH
  • Princeton Biomeditech Corporation
  • QuantuMDx Group Limited
  • Quidel Corporation
  • Radiometer Medical A/S
  • Randox Laboratories Limited
  • RENESA UG
  • Response Biomedical Corp
  • Reszon Diagnostics International Sdn. Bhd.
  • Rheonix, Inc
  • Roche Diagnostic Corporation
  • Samsung Healthcare
  • Savyon Diagnostics
  • Sekisui Diagnostics LLC
  • Siemens Healthineers GmbH
  • Spectral Medical, Inc
  • Sysmex Corporation
  • TECHLAB, Inc.
  • Teco Diagnostics
  • Trinity Biotech PLC
  • Trividia Health
  • Tulip Diagnostics Ltd
  • VedaLab
  • Veredus Laboratories PTE Ltd
  • Vircell
  • WAMA Diagnostica
  • Wave 80 Biosciences
  • Werfen

Market Issues and Trends

An in-depth look at the global POC testing market yields several interesting facts that are explored in this report. Emerging technological innovations in smartphones, biosensors, lab-on-a-chip and wearable devices are influencing the POC landscape. Worldwide Market for Point-of-Care (POC) Diagnostics explores the main issues and trends affecting this market, influencing its move into the future. These include wearables, patient-centered healthcare, regulatory hurdles, and reimbursement challenges. Factors driving the development of POC tests are discussed as well, including patient-focused drivers, medical/healthcare-related drivers, technology drivers, and economic drivers.

Table of Contents

1: Executive Summary
Introduction
Size and Growth of the Market

    • Table 1-1: Global POC Test Market, 2017-2024 (in millions $ at manufacturer level)

Trends Affecting the Market
Market Conclusions

  • Conclusion One — POC Market Must Prove Quality to Overcome Cost
  • Conclusion Two — POC Molecular Diagnostics Make Inroads in Respiratory Disease
  • Conclusion Three — Demand for Prevention and Early Detection Best Answered by POC
  • Conclusion Four — Wearables Trend Positive for POC
  • Conclusion Five — Cost, Reimbursement Remains Largest Hurdle
  • Conclusion Six — Emerged and Emerging Non-U.S. Markets Driver of Growth
  • Conclusion Seven — Urgent and Retail Care Venues Rely on POC

Scope and Methodology
Competitive Outlook

2: Introduction and Overview
Point-of-Care Diagnostics Testing
Industry Regulations
POC Industry Drivers

  • Patient-focused Drivers
  • Medical/Healthcare-related Drivers
  • Technology Drivers
  • Economic Drivers
  • Other Drivers
  • POC Test Types
  • Blood
  • Urine
  • Saliva
  • Hair
  • Optical Technologies
  • Breath

Conditions Evaluated by POC Diagnostic Testing

  • Cancer
  • Cardiovascular Disease
  • Diabetes
  • Drug Abuse
  • Central Nervous System Stimulants
  • Prevalence and Number of Illicit Drug Users
  • Infectious Disease
  • Osteoporosis
  • Pregnancy and Fertility

3: POC Blood Glucose Tests
Types of Blood Glucose Testing

  • Fasting Blood Sugar (FBS)
  • 2-Hour Postprandial Blood Sugar (PPBS)
  • Random Blood Sugar
  • Glucose Tolerance Test
  • Glucose Urine Test
  • Glycated Hemoglobin (HbA1c)

Products

  • Blood Glucose Self-Testing
    • Table 3-1: Selected Glucose Self-Test Meter Innovations
    • Table 3-2: Selected Apps and Glucose Management IT
  • Continuous Self-Testing
  • Glycated Hemoglobin Tests
    • Table 3-3: Selected POC HbA1c Devices
  • Professional

Market Size and Growth

    • Table 3-4: Global POC Glucose (including CGM and HbA1c) Testing Market Analysis, 2017-2024 (in millions of dollars at the manufacturerís level)
    • Table 3-5: Global POC Diabetes Sales by Test Category, 2019-2024 (Glucose, Self-test; Glucose, professional; Glucose, continuous; HbA1c, POC; TOTAL; $ millions)
  • Regional Analysis
    • Figure 3-1: POC Blood Glucose Testing Regional Market Analysis, 2019 (US, Europe, Japan, RoW)
  • POC Glucose Self-Testing
    • Table 3-6: Global POC Glucose Self-Testing Market (excludes continuous glucose devices) 2019-2024 (in millions $ at manufacturer level)
    • Table 3-7: Global POC Continuous Glucose Self-Testing Market 2019-2024 (in millions $ at manufacturer level)
  • POC Glucose Professional Testing
    • Table 3-8: Global POC Glucose Professional Testing Market (excludes HbA1c testing) 2019-2024 (in millions $ at manufacturer level)
    • Table 3-9: Global POC Glucose HbA1c Professional Testing Market 2019-2024 (in millions $ at manufacturer level)

    Competitive Analysis

    • Table 3-10: Global POC Blood Glucose Testing Market, Revenues and Market Share of Leading Suppliers, 2019 (in millions $)
    • Figure 3-2: Global POC Glucose Test Manufacturers by Percent, 2019

4: POC Blood and Electrolytes Testing Market
Types of Blood and Electrolytes Tests

  • Hemoglobin/Hematocrit
  • WBC and Other
  • Blood Gases
  • Electrolytes
    Products

    • Table 4-1: Selected POC Hemoglobin and Hematocrit Systems, 2019
    • Table 4-2: Selected POC Hematology Analyzer Systems, 2019
  • Recent Developments

Market Size and Growth

    • Table 4-3: Global POC Blood and Electrolytes Testing Market Analysis, 2017-2024 (in millions of dollars at the manufacturerís level)
    • Table 4-4: Global POC Blood & Electrolytes Revenues by Test Category, 2019-2024 ($ millions) (Blood Gases & Electrolytes [inc critical care], Hematocrit/Hemoglobin, WBC other routine)
  • Regional Analysis
    • Figure 4-1: POC Blood and Electrolytes Testing Regional Market Analysis, 2019 (US, Europe, Japan, RoW)
  • POC Blood and Electrolyte Self-Testing
    • Table 4-5: Global POC Blood and Electrolyte Self Testing Market Analysis, 2019-2024 (in millions of dollars at the manufacturerís level)
  • POC Blood and Electrolyte Professional Testing
    • Table 4-6: Global POC Blood and Electrolyte Professional Testing Market Analysis, 2019-2024 (in millions of dollars at the manufacturerís level)

Competitive Analysis

    • Table 4-7: Global POC Blood and Electrolyte Testing Market, Revenues and Market Share of Leading Suppliers, 2019 (in millions $)
    • Figure 4-2: Global POC Blood and Electrolyte Testing Market Manufacturers by Percent, 2019

5: POC Rapid Coagulation
Products

    • Table 5-1: Selected POC Coagulation Test Innovations
  • Platelet Testing
    • Table 5-2: Selected Platelet Activity Test Innovations

    Market Size and Growth

    • Table 5-3: Global Rapid Coagulation Testing Market Analysis, 2017-2024 (in millions of dollars at the manufacturerís level)
  • Regional Analysis
    • Figure 5-1: POC Rapid Coagulation Testing Regional Market Analysis, 2019 (US, Europe, Japan, RoW)
  • POC Rapid Coagulation Self-Testing
    • Table 5-4: POC Rapid Coagulation Self-Testing Market Analysis, 2019-2024 (in millions of dollars at the manufacturerís level)
  • POC Rapid Coagulation Professional Testing
    • Table 5-5: POC Rapid Coagulation Professional Testing Market Analysis, 2019-2024 (in millions of dollars at the manufacturerís level)

Competitive Analysis

    • Table 5-6: Global POC Rapid Coagulation Testing Market, Revenues and Market Share of Leading Suppliers, 2019 (in millions$)
    • Figure 5-2: Global POC Rapid Coagulation Testing Market, Market Share % of Leading Suppliers, 2019

6: POC Rapid Cardiac Markers
Products
Market Size and Growth

    • Table 6-1: Total Rapid Cardiac Markers Tests Market Analysis, 2017-2024 (in millions of dollars at the manufacturerís level)
  • Regional Analysis
    • Figure 6-1: POC Rapid Cardiac Markers Testing Regional Market Analysis, 2019 (US; Europe; Japan; Latin America, India, Asia Pacific and the Middle East; RoW)

Competitive Analysis

    • Table 6-2: Global POC Cardiac Markers Test Market, Revenues and Market Share of Leading Suppliers, 2019 (in millions $)
    • Figure 6-2: Global POC Cardiac Test Manufacturers by Percent, 2019

7: POC Substance Abuse
Overview
Products

  • Urine
  • Oral
  • Blood
  • Hair

Market Size and Growth

    • Table 7-1: Global POC Drugs of Abuse Testing Market Analysis, 2017-2024 (in millions of dollars at the manufacturerís level)
  • Regional Analysis
    • Figure 7-1: POC Substance Abuse Testing Regional Market Analysis, 2019 (US, Europe, Japan, RoW)
  • POC Drugs of Abuse Self-Testing
    • Table 7-2: Global POC Drugs of Abuse Self Testing Market, 2019-2024
  • POC Drugs of Abuse Professional Testing
      • Table 7-3: Global POC Drugs of Abuse Professional Testing Market Analysis, 2019-2024 (in millions of dollars at the manufacturerís level)

    Competitive Analysis

    • Table 7-4: Global POC Drugs of Abuse Testing Market, Revenues and Market Share of Leading Suppliers, 2019
    • Figure 7-2: Global POC Drug of Abuse Testing Manufacturers by Percent, 2019

8: POC Pregnancy and Fertility Testing
Products

    • Table 8-1: Selected Pregnancy and Fertility CLIA Waivers (Manufacturer and Instrument / Assay), Manufacturerís Instrument / Device / Assay

Market Size and Growth

    • Table 8-2: Global POC Pregnancy and Fertility Testing Market Analysis, 2017-2024 (in millions of dollars at the manufacturerís level)
  • Regional Analysis
    • Figure 8-1: POC Pregnancy and Fertility Testing Regional Market Analysis, 2019 (US, Europe, Japan, RoW)
  • POC Pregnancy and Fertility Self-Testing
    • Table 8-3: POC Pregnancy and Fertility Self-Testing Market Analysis, 2019-2024 (in millions of dollars at the manufacturerís level)
  • POC Pregnancy and Fertility Professional Testing
    • Table 8-4: POC Pregnancy and Fertility Professional Testing Market Analysis, 2019-2024 (in millions of dollars at the manufacturerís level)

Competitive Analysis

    • Table 8-5: Global POC Pregnancy and Fertility Testing Market, Revenues and Market Share of Leading Suppliers, 2019 (in millions $)
    • Figure 8-2 Global POC Pregnancy and Fertility Testing Manufacturers by Percent, 2019

9: POC Colon Cancer Screening/Fecal Occult Blood Testing
Products

    • Table 9-1: Selected POC Colon Cancer Tests

Market Size and Growth

    • Table 9-2: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market Analysis: 2017-2024 (in millions of dollars at the manufacturerís level)
  • Regional Analysis
    • Figure 9-1: POC Colon Cancer Screening/FOB Testing Regional Market Analysis, 2019 (US, Europe, Japan, RoW)
  • POC Colon Cancer Screening/Fecal Occult Blood Self-Testing
    • Table 9-3: POC Colon Cancer Screening/Fecal Occult Blood Self-Testing Market Analysis, 2019-2024 (in millions of dollars at the manufacturerís level)
  • POC Colon Cancer Screening/ Fecal Occult Blood Professional Testing
    • Table 9-4: POC Colon Cancer Screening/Fecal Occult Blood Professional Testing Market Analysis, 2019-2024 (in millions of dollars at the manufacturerís level)

Competitive Analysis

    • Table 9-5: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market, Revenues and Market Share of Leading Suppliers, 2019 (in millions $)
    • Figure 9-2: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Manufacturers by Percent, 2019

10: POC Infectious Disease Testing
Products

  • HIV and Hepatitis
  • Respiratory
  • STD
  • Tropical Diseases
  • Lyme Disease
  • TB
  • Hospital Acquired Infections
    • Table 10-1: Innovations in POC Infectious Disease Diagnostics

Market Size and Growth

  • Table 10-2: Global POC Infectious Disease Testing Market Analysis: 2017-2024 (in millions of dollars at the manufacturerís level)
  • Regional Analysis
    • Figure 10-1: POC Infectious Disease Testing Regional Market Analysis, 2019 (US, Europe, Japan, RoW)
  • POC Infectious Disease Self-Testing
    • Table 10-3: POC Infectious Disease Self-Testing Market Analysis, 2019-2024 (in millions of dollars at the manufacturerís level)
  • POC Infectious Disease Professional Testing
    • Table 10-4: POC Infectious Disease Professional Testing Market Analysis, 2019-2024 (in millions of dollars at the manufacturerís level)

POC Infectious Disease Testing by Disease Type

  • Table 10-5: Global POC Infectious Disease Revenues and Percent of Infectious Disease Market by Disease Type, 2019 (in millions $) (Influenza, HIV, STD, Hepatitis, Malaria, C. difficile, E. coli, H. pylori, Home Test/OTC, Others, Total)

Competitive Analysis

    • Table 10-6: Global POC Infectious Disease Testing Market, Revenues and Market Share of Leading Suppliers, 2019 (in millions $)
    • Figure 10-2: Global POC Infectious Disease Test Manufacturers by Percent, 2019

11: POC Lipid Testing
Products
Market Size and Growth

    • Table 11-1: Global POC Lipid Testing Market Analysis, 2017-2024 (in millions of dollars at the manufacturerís level)
  • Regional Analysis
    • Figure 11-1: POC Lipid Testing Regional Market Analysis, 2019 (US, Europe, Japan, RoW)
  • POC Lipid Self-Testing
    • Table 11-2: POC Lipid Self-Testing Market Analysis, 2019-2024 (in millions of dollars at the manufacturerís level)
  • POC Lipid Professional Testing
    • Table 11-3: POC Lipid Testing Market Analysis, 2019-2024 (in millions of dollars at the manufacturerís level)

Competitive Analysis

    • Table 11-4: Global POC Lipid Testing Market, Revenues and Market Share of Leading Suppliers, 2019 (in millions $)
    • Figure 11-2: Global POC Lipid Testing Manufacturers by Percent, 2019

12: POC Cancer Tumor Marker Testing
Products

    • Table 12-1: Selected Companies Developing and/or Marketing POC Tests for Oncology Indications

Market Size and Growth

    • Table 12-2: Global POC Cancer Testing Market Analysis, 2017-2024 (in millions of dollars at the manufacturerís level)
  • Regional Analysis
    • Figure 12-1: POC Cancer Tumor Marker Testing Regional Market Analysis, 2019 (US, Europe, Japan, RoW)

Competitive Analysis

    • Table 12-3: Global POC Cancer Testing Market, Revenues and Market Share of Leading Suppliers, 2019 (in millions $)
    • Figure 12-2: Global POC Cancer Testing Manufacturers by Percent, 2019

13: POC Urine Testing
Products
Market Size and Growth

    • Table 13-1: Global POC Urine Testing Market Analysis, 2017-2024 (in millions of dollars at the manufacturerís level)
  • Regional Analysis
    • Figure 13-1: POC Urine Testing Regional Market Analysis, 2019 (US, Europe, Japan, RoW)
  • POC Urine Self-Testing
    • Table 13-2: POC Urine Self-Testing Market Analysis, 2019-2024 (in millions of dollars at the manufacturerís level)
  • POC Urine Test Professional Testing
    • Table 13-3: POC Urine Professional Testing Market Analysis, 2019-2024 (in millions of dollars at the manufacturerís level)

Competitive Analysis

    • Table 13-4: Global POC Urine Testing Market, Revenues and Market Share of Leading Suppliers, 2019 (in millions $)
    • Figure 13-2: Global POC Urine Strip Testing Manufacturers by Percent, 2019

14: Miscellaneous POC Testing
Microbiology
TSH
Allergy
Autoimmune
Others
Market Size and Growth

    • Table 14-1: Global Miscellaneous POC Testing Market Analysis, 2017-2024 (in millions of dollars at the manufacturerís level)
    • Table 14-2: Global POC Miscellaneous Sales by Test Category, 2019-2024 (Microbiology, TSH, Allergy, Autoimmune, Others TOTAL; $ millions) (Microbiology, TSH, Allergy, Autoimmune, Others, Total)
  • Regional Analysis
    • Figure 14-1: POC Miscellaneous Testing Regional Market Analysis, 2019 (US, Europe, Japan, RoW)

15: Issues and Trends
Overview
Wearables

    • Table 15-1: Selected Wearable Devices

Mobile Healthcare Technologies
Patient-centered Healthcare

  • Barbershops

Breath Test Advances

    • Table 15-2: Selected Disease Markers in Exhaled Breath

Regulatory Hurdles
Reimbursement Challenges
PAMA
Competition
POC and Molecular Diagnostics

    • Table 15-3: Selected Market Available Molecular POC Diagnostic Platforms

POC and Biosensors and Microfluidics

    • Table 15-4: Selected FDA-Approved Microfluidic-based POC Tests 2019
    • Table 15-5: Selected Biochip and Biosensor Players, 2019

Emerging POC Technologies
POC Connectivity
Multiplexed POC Testing

    • Figure 15-1: Multiplexed POC Testing Schematic

The Emergence of Non-invasive Technologies

  • Saliva and Swab
  • Optical Techniques
  • Near-infrared Scanning
  • Volatolomics

16: Total Global POC Testing Market and Competitor Analysis
Market Overview

    • Table 16-1: Global POC Test Market, 2017-2024 (in millions $ at manufacturer level)

Market Analysis by Product Categories

    • Table 16-2: Global POC Testing Market Analysis by Product Category, 2019 (in millions $) (Self-Testing, Professional Testing, Total)

Market Analysis by Subcategory

  • POC Self-Testing
    • Table 16-3: Global POC Self-Testing Market Analysis by Product Category, 2019 (in millions$) (Glucose [includes CGM], Blood and electrolytes, Pregnancy & Fertility, Fecal Occult Blood, Rapid Coagulation, Drugs of Abuse, Urine, Infectious Disease, Lipid, Total)
    • Figure 16-1: Global POC Self-Testing Market Analysis by Product Category, 2019 (by %) (Infectious Disease, Urine, DOA, Coagulation, FOB, Pregnancy, Glucose)
  • POC Professional Testing
    • Table 16-4: Global POC Professional Testing Market Analysis by Product Subcategory, 2019 (in millions$) (Drugs of Abuse, Glucose includes HbA1c, Blood & Electrolytes, Infectious Disease, Fecal Occult Blood, Rapid Coagulation, Cardiac Markers, Lipid, Pregnancy & Fertility, Miscellaneous, Urine, Cancer Tumor Markers, Total)
    • Figure 16-2: Global POC Professional Testing Market Analysis by Product Subcategory, 2019 (by %) (Tumor Markers, Urine, Misc, Pregnancy, Lipid, Cardiac Markers, Rapid Coag, FOB, Infectious Disease, Blood/ Electrolytes, Glucose/ HbA1c, DOA)
  • POC Testing by End-Use
    • Figure 16-3: POC Testing by End-User, 2019 (%; Hospitals, Others)

Market by Device Technology

    • Figure 16-4: Global POC Market by Technology by Sales, 2019 (LFA, Biosensors, Analyzers, Strips)

Market Analysis by Country

  • United States
    • Table 16-5: US POC Testing Market Analysis, 2019-2024 (in millions of dollars at the manufacturerís level)
  • Europe
    • Table 16-6: Europe POC Testing Market Analysis, 2019-2024 (in millions of dollars at the manufacturerís level)
    • Table 16-7: Global POC Testing Market Analysis by European Region, 2019 (in millions $) (W. Europe, E. Europe, Total)
    • Figure 16-5: Europe POC Testing Percentage Participation, by Country, 2019 (Germany, UK, France, Italy, Switzerland/ Sweden, Spain, Other)
  • Japan
    • Table 16-8: Japan POC Testing Market Analysis, 2019-2024 (in millions of dollars at the manufacturerís level)
  • Rest of World
    • Table 16-9: Global POC Testing Market Analysis by Rest of World Region/Country, 2019 (in millions $) (Latin America and Mexico, China, Australia, South Korea, India, Other, Total)
    • Figure 16-6: Global POC Testing Market Analysis by Rest of World Region/Country, 2019 (Latin Am/ Mexico, China, South Korea, Australia, India, Others)
    • Table 16-10: Global POC Testing Analysis by Region/Country, 2019 (in millions $) (United States, Europe, Japan, ROW, Total)
    • Figure 16-7: Global POC Testing Market Analysis Percent by Region/Country, 2019 (US, Europe, Japan, RoW)

Competitive Analysis

    • Table 16-11: Global POC Testing Market Revenues and Market Share of Leading Suppliers, 2019 (in millions $)
    • Figure 16-8: Global POC Testing Market Share by Leading Suppliers, 2019

17: Corporate Profiles
Overview
1 Step Detect Associates, LLC

    • Table 17-1: 1 Step Detect Associates Corporate Summary
  • Company Overview
  • Products

Abaxis, Inc.

    • Table 17-2: Abaxis Corporate Summary
  • Company Overview
  • Products

Abbott Laboratories

    • Table 17-3: Abbott Corporate Summary
  • Company Overview
  • Alere Acquisition Update
  • Products
  • Performance Review
    • Table 17-4: Abbott Revenues 2017-2019 (in millions $)

Abingdon Health, Ltd.

    • Table 17-5: Abingdon Health Corporate Summary
  • Company Overview
  • Products

AccessBio, Inc.

    • Table 17-6: AccessBio Corporate Summary
  • Company Overview
  • Products

AccuBioTech Co, Ltd.

    • Table 17-7: AccuBioTech Corporate Summary
  • Company Overview
  • Products

ACON Laboratories, Inc

    • Table 17-8: ACON Laboratories Corporate Summary
  • Company Overview
  • Products

Aerscher Diagnostics, LLC

    • Table 17-9: Aerscher Diagnostics Corporate Summary
  • Company Overview
  • Products

Akers Biosciences, Inc.

    • Table 17-10: Akers Biosciences Corporate Summary
  • Company Overview
  • Products
  • Company Financials
    • Table 17-11: Akers Corporation Revenue (2016-2019) ($ thousands)

Alfa Scientific Designs, Inc

    • Table 17-12: Alfa Scientific Corporate Summary
  • Company Overview
  • Products

American Bio Medica Corporation

    • Table 17-13: American Bio Medica Corporate Summary
  • Company Overview
  • Products
  • Performance Review
    • Table 17-14: American Bio Medica Corporation Revenue (2016-2019) ($ millions)

AmniSure International

    • Table 17-15: AmniSure International Corporate Summary
  • Company Overview
  • Products

Aquila Diagnostic Systems, Inc

    • Table 17-16: Aquila Diagnostic Systems Summary
  • Company Overview
  • Products

Arkray, Inc.

    • Table 17-17: Arkray Corporate Summary
  • Company Overview
  • Products

Arlington Scientific, Inc.

    • Table 17-18: Arlington Scientific Corporate Summary
  • Company Overview
  • Products

Artron Laboratories, Inc

    • Table 17-19: Artron Laboratories Corporate Summary
  • Company Overview
  • Products

Ascensia Diabetes Care Holdings AG

    • Table 17-20: Ascensia Diabetes Care Corporate Summary
  • Company Overview
  • Products

Ativa Medical Corporation

    • Table 17-21: Ativa Medical Corporate Summary
  • Company Overview
  • Products

Atlas Link Biotech Co., Ltd

    • Table 17-22: Atlas Link Biotech Corporate Summary
  • Company Overview
  • Products

Audit Diagnostics

    • Table 17-23: Audit Diagnostics Corporate Summary
  • Company Overview
  • Products

Augurix Diagnostic

    • Table 17-24: Augurix Diagnostic Corporate Summary
  • Company Overview
  • Products

Autobio Diagnostics Co., Ltd

    • Table 17-25: Autobio Diagnostics Corporate Summary
  • Company Overview
  • Products

Axxin

    • Table 17-26: Axxin Corporate Summary
  • Company Overview
  • Products

Beckman Coulter, Inc

    • Table 17-27: Beckman Coulter Corporate Summary
  • Company Overview
  • Products
  • Company Financials
    • Table 17-28: Beckman Coulter Revenue (2016-2019) ($ millions)

Becton Dickinson (BD)

    • Table 17-29: BD Corporate Summary
  • Company Overview
  • Products
  • Company Financials
    • Table 17-30: BD Corporation Revenue (2016-2019) ($ millions)

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

    • Table 17-31: Beijing Wantai Biological Pharmacy Enterprise Corporate Summary
  • Company Overview
  • Products

Bhat Bio-Tech India Private Ltd. (BBI)

    • Table 17-32: Bhat Bio-Tech India Private Corporate Summary
  • Company Overview
  • Products

binx health

    • Table 17-33: binx health Corporate Summary
  • Company Overview
  • Products

bioLytical Laboratories

    • Table 17-34: bioLytical Laboratories Corporate Summary
  • Company Overview
  • Products

BioMedomics, Inc

    • Table 17-35: BioMedomics Corporate Summary
  • Company Overview
  • Products

Biomeme, Inc

    • Table 17-36: Biomeme Corporate Summary
  • Company Overview
  • Products

Biomerica, Inc.

    • Table 17-37: Biomerica Corporate Summary
  • Company Overview
  • Products
  • Company Financials
    • Table 17-38: Biomerica Corporation Revenue (2016-2019) ($ millions)

bioMÈrieux SA

    • Table 17-39: bioMÈrieux SA Corporate Summary
  • Company Overview
  • Products
  • Company Financials
    • Table 17-40: bioMÈrieux Revenues (2016-2019) ($ millions)

Biophor Diagnostics, Inc

    • Table 17-41: Biophor Diagnostics Corporate Summary
  • Company Overview
  • Products

Bio-Rad Laboratories Inc.

    • Table 17-42: Bio-Rad Labs Corporate Summary
  • Company Overview
  • Products
  • Company Financials
    • Table 17-43: Bio-Rad Corporation Revenue (2016-2019) ($ millions)

Bioscan Screening Systems, Inc.

    • Table 17-44: Bioscan Screening Systems Corporate Summary
  • Company Overview
  • Products

Biosensia Ltd.

    • Table 17-45: Biosensia Corporate Summary
  • Company Overview
  • Products

Biotron Diagnostics, Inc.

    • Table 17-46: Biotron Diagnostics Corporate Summary
  • Company Overview
  • Products

BNTX Inc.

    • Table 17-47: BNTX Corporate Summary
  • Company Overview
  • Products

Boditech Med Inc

    • Table 17-48: Boditech Med Corporate Summary
  • Company Overview
  • Products

Boson Biotech Co. Ltd

    • Table 17-49: Boson Biotech Corporate Summary
  • Company Overview
  • Products

Calypte Biomedical Corporation

    • Table 17-50: Calypte Biomedical Corporate Summary
  • Company Overview
  • Products

CARE Products, Inc.

    • Table 17-51: CARE Products Corporate Summary
  • Company Overview
  • Products

Cepheid, Inc

    • Table 17-52: Cepheid Corporate Summary
  • Company Overview
  • Products
  • Performance Review
    • Table 17-53: Cepheid Revenues (2016-2019) ($ millions)

Chembio Diagnostics, Inc.

    • Table 17-54: Chembio Diagnostic Corporate Summary
  • Company Overview
  • Products
  • Performance Review
    • Table 17-55: Chembio Diagnostics Revenues (2016-2019) ($ millions)

Church & Dwight Co. Inc

    • Table 17-56: Church & Dwight Corporate Summary
  • Company Overview
  • Products
  • Performance Review
    • Table 17-57: Church & Dwight Revenues (2016-2019) ($ millions)

Clarity Diagnostics, LLC

    • Table 17-58: Clarity Diagnostics Corporate Summary
  • Company Overview
  • Products

Confirm Biosciences

    • Table 17-59: Confirm Biosciences Corporate Summary
  • Company Overview
  • Products

CTK Biotech, Inc.

    • Table 17-60: CTK Biotech Corporate Summary
  • Company Overview
  • Products

Daktari Diagnostics

    • Table 17-61: Daktari Diagnostics Corporate Summary
  • Company Overview
  • Products

Danaher Corporation

    • Table 17-62: Danaher Corporation Summary
  • Company Overview
  • Products
  • Company Financials
    • Table 17-63: Danaher Revenues (2016-2019) ($ millions)

Dexcom, Inc

    • Table 17-64: Dexcom Corporate Summary
  • Company Overview
  • Products
  • Performance Review
    • Table 17-65: Dexcom Revenues (2016-2019) ($ millions)

DIALAB GmbH

    • Table 17-66: DIALAB Corporate Summary
  • Company Overview
  • Products
    DiaSys Diagnostic Systems GmbH
    • Table 17-67: DiaSys Diagnostic Systems Corporate Summary
  • Company Overview
  • Products

Diazyme Laboratories, Inc.

    • Table 17-68: Diazyme Laboratories Corporate Summary
  • Company Overview
  • Products

DNA Electronics Ltd. (DNAe)

    • Table 17-69: DNA Electronics Corporate Summary
  • Company Overview
  • Products

Dr‰gerwerk AG & Co. KGaA

    • Table 17-70: Dr‰gerwerk Corporate Summary
  • Company Overview
  • Products
  • Company Financials
    • Table 17-71: Dr‰gerwerk Revenues (2016-2019) ($ millions)

Dr. Fooke-Achterrath Laboratorien GmbH

    • Table 17-72: Dr. Fooke-Achterrath Laboratorien Corporate Summary
  • Company Overview
  • Products

DRG International, Inc.

    • Table 17-73: DRG International Corporate Summary
  • Company Overview
  • Products

DxGen Corp.

    • Table 17-74: DxGen Corporate Summary
  • Company Overview
  • Products

Eiken Chemical Co Ltd.

    • Table 17-75: Eiken Chemical Corporate Summary
  • Company Overview
  • Products
  • Performance Review
    • Table 17-76: Eiken Chemical Revenues (2016-2019) ($ millions)

EKF Diagnostics Holdings plc

    • Table 17-77: EKF Diagnostics Corporate Summary
  • Company Overview
  • Products
  • Performance Review
    • Table 17-78: EKF Diagnostics Revenues (2016-2019) ($ millions)

ELITechGroup, Inc.

    • Table 17-79: ELITechGroup Corporate Summary
  • Company Overview
  • Products

Enterix, Inc. (Clinical Genomics)

    • Table 17-80: Enterix Corporate Summary
  • Company Overview
  • Products

Entopsis

    • Table 17-81: Entopsis Corporate Summary
  • Company Overview
  • Products

Eurobio Scientific

    • Table 17-82: Eurobio Scientific Corporate Summary
  • Company Overview
  • Products

Eurolyser Diagnostica GmbH

    • Table 17-83: Eurolyser Diagnostica Corporate Summary
  • Company Overview
  • Products

Exact Sciences

    • Table 17-84: Exact Sciences Corporate Summary
  • Company Overview
  • Products
  • Performance Review
    • Table 17-85: Exact Sciences Revenues (2016-2019) ($ millions)

Exalenz Bioscience Ltd.

    • Table 17-86: Exalenz Bioscience Corporate Summary
  • Company Overview
  • Products
  • Performance Review
    • Table 17-87: Exalenz Bioscience Revenues (2016-2019) ($ millions)

EY Laboratories

      • Table 17-88: EY Laboratories Corporate Summary
  • Company Overview
  • ProductsFio Corporation
      • Table 17-89: Fio Corporate Summary
  • Company Overview
  • ProductsFirst Check Diagnostics LLC
      • Table 17-90: First Check Diagnostics Corporate Summary
  • Company Overview
  • ProductsGenBio
      • Table 17-91: GenBio Corporate Summary
  • Company Overview
  • Productsgenedrive plc
      • Table 17-92: genedrive Corporate Summary
  • Company Overview
  • Products
  • Performance Review
      • Table 17-93: genedrive Revenues (2016-2019) ($ millions)

    GenePOC

      • Table 17-94: GenePOC Corporate Summary
  • Company Overview
  • ProductsGeTein BioMedical, Inc.
      • Table 17-95: GeTein Corporate Summary
  • Company Overview
  • ProductsGlysBy snc
      • Table 17-96: GlysBy Corporate Summary
  • Company Overview
  • ProductsHelena Laboratories
      • Table 17-97: Helena Laboratories Corporate Summary
  • Company Overview
  • ProductsHemosure, Inc.
      • Table 17-98: Hemosure Corporate Summary
  • Company Overview
  • ProductsHORIBA, Ltd.
      • Table 17-99: HORIBA Corporate Summary
  • Company Overview
  • Products
  • Performance Review
      • Table 17-100: HORIBA Revenues (2016-2019) ($ millions)

    Immunosciences Lab, Inc.

      • Table 17-101: Immunosciences Lab Corporate Summary
  • Company Overview
  • ProductsImmunostics, Inc
      • Table 17-102: Immunostics Corporate Summary
  • Company Overview
  • ProductsInSilixa, Inc
      • Table 17-103: InSilixa Corporate Summary
  • Company Overview
  • ProductsInstrumentation Laboratory
      • Table 17-104: Instrumentation Laboratory Corporate Summary
  • Company Overview
  • ProductsJAL Innovation PTE LTD
      • Table 17-105: JAL Innovation Corporate Summary
  • Company Overview
  • ProductsJant Pharmacal Corporation
      • Table 17-106: Jant Pharmacal Corporate Summary
  • Company Overview
  • ProductsJ. Mitra & Co Pvt. Ltd
      • Table 17-107: J. Mitra Corporate Summary
  • Company Overview
  • ProductsLamdaGen Corporation
      • Table 17-108: LamdaGen Corporate Summary
  • Company Overview
  • ProductsLifeScan, Inc
      • Table 17-109: LifeScan Corporate Summary
  • Company Overview
  • ProductsLifeSign, LLC
      • Table 17-110: LifeSign Corporate Summary
  • Company Overview
  • ProductsLoop Medical
      • Table 17-111: Loop Medical Corporate Summary
  • Company Overview
  • ProductsMacherey-Nagel GmbH & Co. KG
      • Table 17-112: Macherey-Nagel Corporate Summary
  • Company Overview
  • ProductsMagnasense Technologies
      • Table 17-113: Magnasense Technologies Corporate Summary
  • Company Overview
  • ProductsMBio Diagnostics, Inc
      • Table 17-114: MBio Diagnostics Corporate Summary
  • Company Overview
  • ProductsMedix Biochemica
      • Table 17-115: Medix Biochemica Corporate Summary
  • Company Overview
  • ProductsMedMira, Inc
      • Table 17-116: MedMira Corporate Summary
  • Company Overview
  • Products
  • Performance Review
      • Table 17-117: MedMira Revenues (2016-2019) ($ thousands)

    Medtronic, Inc.

      • Table 17-118: Medtronic Corporate Summary
  • Company Overview
  • Products
  • Performance Review
      • Table 17-119: Medtronic Revenues (2016-2019) ($ millions)

    A. Menarini Diagnostics srl.

      • Table 17-120: Menarini Diagnostics Corporate Summary
  • Company Overview
  • ProductsMeridian Bioscience, Inc
      • Table 17-121: Meridian Bioscience Corporate Summary
  • Company Overview
  • Products
  • Performance Review
      • Table 17-122: Meridian Bioscience (2016-2019) ($ millions)

    MiCo BioMed USA

      • Table 17-123: MiCo BioMed Summary
  • Company Overview
  • ProductsNano-Ditech Corporation
      • Table 17-124: Nano-Ditech Corporate Summary
  • Company Overview
  • ProductsNG Biotech
      • Table 17-125: NG Biotech Corporate Summary
  • Company Overview
  • ProductsNoble Medical, Inc
      • Table 17-126: Noble Medical Corporate Summary
  • Company Overview
  • ProductsNova Biomedical Corp.
      • Table 17-127: Nova Biomedical Corporate Summary
  • Company Overview
  • ProductsNuGenerex Diagnostics
      • Table 17-128: NuGenerex Diagnostics Corporate Summary
  • Company Overview
  • ProductsOasis Diagnostics Corporation
      • Table 17-129: Oasis Diagnostics Corporate Summary
  • Company Overview
  • ProductsOperon S.A.
      • Table 17-130: Operon Corporate Summary
  • Company Overview
  • ProductsOPKO Health, Inc
      • Table 17-131: OPKO Health Corporate Summary
  • Company Overview
  • Products
  • Performance Review
      • Table 17-132: OPKO Health Revenues (2016-2019) ($ millions)

    OPTI Medical Systems, Inc

      • Table 17-133: OPTI Medical Corporate Summary
  • Company Overview
  • ProductsOraSure Technologies, Inc.
      • Table 17-134: OraSure Technologies Corporate Summary
  • Company Overview
  • Products
      • Table 17-135: Selected OraSure Products
  • Performance Review
      • Table 17-136: OraSure Revenues (2016-2019) ($ millions)

    Polymedco, Inc

      • Table 17-137: Polymedco Corporate Summary
  • Company Overview
  • ProductsPolymed Therapeutics Inc.
      • Table 17-138: Polymed Therapeutics Corporate Summary
  • Company Overview
  • ProductsPolymer Technologies, Inc (PTS Diagnostics)
      • Table 17-139: Polymer Technologies Corporate Summary
  • Company Overview
  • ProductsPreventis GmbH
      • Table 17-140: Preventis Corporate Summary
  • Company Overview
  • ProductsPrinceton Biomeditech Corporation
      • able 17-141: Princeton Biomeditech Corporate Summary
    • Company Overview
    • Products

    QuantuMDx Group Limited

      • Table 17-142: QuantuMDx Group Corporate Summary
  • Company Overview
  • ProductsQuidel Corporation
      • Table 17-143: Quidel Corporate Summary
  • Company Overview
  • Products
  • Performance Review
      • Table 17-144: Quidel Revenues (2016-2019) ($ millions)

    Radiometer Medical A/S

      • Table 17-145: Radiometer Medical Corporate Summary
  • Company Overview
  • Products
  • Performance Review
      • Table 17-146: Radiometer (2016-2019) ($ millions)

    Randox Laboratories Limited

      • Table 17-147: Randox Labs Corporate Summary
  • Company Overview
  • ProductsRENESA UG
      • Table 17-148: RENESA UG Corporate Summary
  • Company Overview
  • ProductsResponse Biomedical Corp
      • Table 17-149: Response Biomedical Corporate Summary
  • Company Overview
  • ProductsReszon Diagnostics International Sdn. Bhd.
      • Table 17-150: Reszon Diagnostics Corporate Summary
  • Company Overview
  • ProductsRheonix, Inc
      • Table 17-151: Rheonix Corporate Summary
  • Company Overview
  • ProductsRoche Diagnostic Corporation
      • Table 17-152: Roche Diagnostic Corporate Summary
  • Company Overview
  • Products
      • Table 17-153: Roche POC Marketed Products
  • Performance Review
      • Table 17-154: Roche Diagnostics (2016-2019) ($ millions)

    Samsung Healthcare

      • Table 17-155: Samsung Healthcare Corporate Summary
  • Company Overview
  • ProductsSavyon Diagnostics
      • Table 17-156: Savyon Diagnostics Corporate Summary
  • Company Overview
  • ProductsSekisui Diagnostics LLC
      • Table 17-157: Sekisui Diagnostics Corporate Summary
  • Company Overview
  • ProductsSiemens Healthineers GmbH
      • Table 17-158: Siemens Healthineers Corporate Summary
  • Company Overview
  • Products
  • Performance Review
      • Table 17-159: Siemens Healthineers (2016-2019) ($ millions)

    Spectral Medical, Inc

      • Table 17-160: Spectral Medical Summary
  • Company Overview
    Sysmex Corporation

      • Table 17-161: Sysmex Corporate Summary
  • Company Overview
  • Products
  • Performance Review
      • Table 17-162: Sysmex (2016-2019) ($ millions)

    TECHLAB, Inc.

      • Table 17-163: TECHLAB Corporate Summary
  • Company Overview
  • ProductsTeco Diagnostics
      • Table 17-164: Teco Diagnostics Corporate Summary
  • Company Overview
  • ProductsTrinity Biotech PLC
      • Table 17-165: Trinity Biotech Corporate Summary
  • Company Overview
  • Products
  • Performance Review
      • Table 17-166: Trinity Biotech Revenue (2016-2019) ($ millions)

    Trividia Health

      • Table 17-167: Trividia Health Corporate Summary
  • Company Overview
  • ProductsTulip Diagnostics Ltd
      • Table 17-168: Tulip Diagnostics Corporate Summary
  • Company Overview
  • Product
    VedaLab

      • Table 17-169: VedaLab Corporate Summary
  • Company Overview
  • ProductsVeredus Laboratories PTE Ltd
      • Table 17-170: Veredus Labs Corporate Summary
  • Company Overview
  • ProductsVircell
      • Table 17-171: Vircell Corporate Summary
  • Company Overview
  • ProductsWAMA Diagnostica
      • Table 17-172: WAMA Diagnostica Corporate Summary
  • Company Overview
  • ProductsWave 80 Biosciences
      • Table 17-173: Wave 80 Biosciences Corporate Summary
  • Company Overview
  • ProductsWerfen
      • Table 17-174: Werfen Corporate Summary
  • Company Overview
  • Products
  • Performance Review
      • Table 17-175: Werfen (2016-2019) ($ millions)
    Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition
    May 13, 2025
    In Vitro Diagnostic (IVD) Trends and Market Update, 2025
    April 7, 2025
    In Vitro Diagnostics Business Outlook, 2025 (6 Issues)
    April 3, 2025
    Molecular Diagnostics Quarterly Datastream, 2025
    April 2, 2025

Related products

  • Placeholder image

    Medical Imaging Markets, Volume III – Ultrasound

    $1,200.00 – $5,990.00
  • Placeholder image

    Diagnostics for Emerging Infectious Disease Threats Volume I: Prion Disease

    $1,496.00 – $2,992.00
  • Placeholder image

    The U.S. Market for Over-the-Counter Pediatric Medication and Healthcare Products

    $3,000.00 – $6,000.00
  • Placeholder image

    Worldwide Point of Care (POC): Are Decentralized Clinical Diagnostics a Cost Drain or Revenue Driver?

    $1,500.00 – $5,990.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
The Market and Future Potential for Molecular Point of CareArtificial Intelligence Markets in IVD
Scroll to top